Virios Therapeutics Correlations
| VIRIDelisted Stock | USD 3.95 0.00 0.00% |
The current 90-days correlation between Virios Therapeutics Llc and LMF Acquisition Opportunities is 0.14 (i.e., Average diversification). The correlation of Virios Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Virios Therapeutics Correlation With Market
Significant diversification
The correlation between Virios Therapeutics Llc and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Virios Therapeutics Llc and DJI in the same portfolio, assuming nothing else is changed.
Virios |
Moving together with Virios Stock
| 0.73 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.62 | EC | Ecopetrol SA ADR Sell-off Trend | PairCorr |
| 0.67 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.73 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.68 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against Virios Stock
| 0.73 | DIS | Walt Disney Sell-off Trend | PairCorr |
| 0.71 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.7 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.69 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
| 0.66 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.65 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.5 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.47 | HPQ | HP Inc | PairCorr |
| 0.42 | SSNLF | Samsung Electronics | PairCorr |
| 0.31 | XOM | Exxon Mobil Corp Fiscal Year End 7th of February 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Virios Stock performing well and Virios Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Virios Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ICU | 4.03 | (1.09) | 0.00 | (0.90) | 0.00 | 7.98 | 31.31 | |||
| ZVSA | 3.98 | (0.81) | 0.00 | 0.50 | 0.00 | 7.57 | 78.93 | |||
| SONN | 4.74 | (0.93) | 0.00 | 1.59 | 0.00 | 12.31 | 37.58 | |||
| REVB | 3.64 | (0.67) | 0.00 | (0.22) | 0.00 | 8.97 | 34.52 | |||
| EFTR | 7.57 | (5.30) | 0.00 | (0.79) | 0.00 | 8.70 | 88.91 | |||
| ZURA | 3.81 | (0.65) | 0.00 | (0.17) | 0.00 | 7.95 | 26.70 | |||
| NAVB | 6.04 | (1.04) | 0.00 | 2.21 | 0.00 | 12.50 | 40.40 | |||
| IMMX | 4.34 | (0.06) | (0.01) | 0.08 | 4.54 | 9.38 | 32.68 | |||
| CNSP | 4.45 | (0.37) | 0.00 | (0.28) | 0.00 | 9.09 | 39.29 | |||
| CYTO | 3.65 | (1.05) | 0.00 | (4.93) | 0.00 | 7.32 | 22.81 |
Delisting Warning - VIRI
Virios Therapeutics Llc was delisted
| The entity Virios Therapeutics Llc with a symbol VIRI was delisted from NASDAQ Exchange. Please try Dogwood Therapeutics, with a symbol DWTX from now on. Check all delisted instruments accross multiple markets. |
Virios Therapeutics Corporate Management
| Gregory Duncan | Chairman CEO | Profile | |
| Carol Duffy | Chief Advisor | Profile | |
| Ralph MPH | Senior Operations | Profile | |
| Angela Walsh | SVP CFO | Profile |
Still Interested in Virios Therapeutics Llc?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.